Label: GOLD COSMETICS ADI CLEAR- hydroquinone cream cream

  • Category: HUMAN OTC DRUG LABEL

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated November 16, 2017

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Hydroquinone 5%

  • PURPOSE

    Face cream for gradual fading of dark spots

  • INDICATIONS & USAGE

    Face cream for gradual fading of dark spots

    Apply a very thin layer once a day, only at night, all over the face

  • DOSAGE & ADMINISTRATION

    Apply a very thin layer once a day, only at night, all over the face​

  • WARNINGS

    Warnings:

    • For external use only
    • Avoid contact with eyes
    • If contact occurs, rinse eyes thoroughly with water
  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children

  • INACTIVE INGREDIENT

  • PRINCIPAL DISPLAY PANEL

    Gold Cosmetics Adi Clear

  • INGREDIENTS AND APPEARANCE
    GOLD COSMETICS ADI CLEAR 
    hydroquinone cream cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69435-1704
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE) HYDROQUINONE5 mg  in 100 mg
    Inactive Ingredients
    Ingredient NameStrength
    GLYCERIN (UNII: PDC6A3C0OX)  
    JOJOBA OIL (UNII: 724GKU717M)  
    DECYL OLEATE (UNII: ZGR06DO97T)  
    SODIUM DITHIONATE (UNII: RPF7Z41GAW)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
    WATER (UNII: 059QF0KO0R)  
    CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
    STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
    CETEARETH-30 (UNII: 1R9DCZ5FOX)  
    STEARETH-21 (UNII: 53J3F32P58)  
    STEARETH-2 (UNII: V56DFE46J5)  
    EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
    CHLORPHENESIN (UNII: I670DAL4SZ)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    ALLANTOIN (UNII: 344S277G0Z)  
    ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69435-1704-130 mg in 1 TUBE; Type 0: Not a Combination Product06/05/2017
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart358A06/05/2017
    Labeler - Peer Pharm Ltd (514678390)
    Registrant - Peer Pharm Ltd (514678390)
    Establishment
    NameAddressID/FEIBusiness Operations
    Peer Pharm Ltd514678390manufacture(69435-1704) , label(69435-1704)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!